Government advisers in Germany are reviewing the programme there after leading scientists said the jab was failing to live up to expectations on the number of cervical cancer cases it might prevent. Now critics say Scottish health advisors , who gave the go-ahead for a £64 million immunisation programme involving thousands of schoolgirls, should review the evidence as well.
Germany’s Robert Koch Institute, which makes recommendations on the public funding of vaccines, is reviewing its programme after 13 experts called for a reassessment of its HPV vaccination programme and an end to “misleading information” about the effectiveness of the jab.
The HPV vaccine is said to be effective in preventing the two strains of the virus that cause 70 per cent of cervical cancer cases, and scientists have assumed this means the vaccine can prevent 70 per cent of cases of cervical cancer.
But the German experts said the assumptions simply did not stand up to scrutiny, and that women remained at risk from other strains of the virus.